Abstract
Our objective for Current Neurovascular Research is to consistently provide a broad platform for leading scientific inquiry of both neuronal and vascular origins in neuroscience. To this end, our current issue is no exception to this rule and offers the opinions and hypotheses of scientific leaders from a broad spectrum of investigative fields. In this issue, the initial article by Lehmann et al. outlines the function of cellular water-selective channels in the central nervous system, termed aquaporins, and the unique role that these channels play in water transport during disorders such as cerebral ischemia, trauma, and neoplasms. Subsequently, the next series of articles in this issue highlight novel therapeutic strategies for a variety of nervous system disorders. Sakamaki presents the molecular mechanisms that can determine vascular endothelial cell injury in conjunction with the cellular and environmental factors that can repair damaged vascular cells and foster new endothelial cell growth during angiogenesis. In another article by Panchal et al., cellular mediators of abnormal
Keywords: Aquaporins, apoptosis, neuropathies
Current Neurovascular Research
Title: From the Editors Perspective: Aquaporins to Apoptosis
Volume: 1 Issue: 4
Author(s): Kenneth Maiese
Affiliation:
Keywords: Aquaporins, apoptosis, neuropathies
Abstract: Our objective for Current Neurovascular Research is to consistently provide a broad platform for leading scientific inquiry of both neuronal and vascular origins in neuroscience. To this end, our current issue is no exception to this rule and offers the opinions and hypotheses of scientific leaders from a broad spectrum of investigative fields. In this issue, the initial article by Lehmann et al. outlines the function of cellular water-selective channels in the central nervous system, termed aquaporins, and the unique role that these channels play in water transport during disorders such as cerebral ischemia, trauma, and neoplasms. Subsequently, the next series of articles in this issue highlight novel therapeutic strategies for a variety of nervous system disorders. Sakamaki presents the molecular mechanisms that can determine vascular endothelial cell injury in conjunction with the cellular and environmental factors that can repair damaged vascular cells and foster new endothelial cell growth during angiogenesis. In another article by Panchal et al., cellular mediators of abnormal
Export Options
About this article
Cite this article as:
Maiese Kenneth, From the Editors Perspective: Aquaporins to Apoptosis, Current Neurovascular Research 2004; 1 (4) . https://dx.doi.org/10.2174/1567202043362054
DOI https://dx.doi.org/10.2174/1567202043362054 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Editorial (Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases)
Current Neuropharmacology Genetic Bases of Progressive Supranuclear Palsy: The MAPT Tau Disease
Current Medicinal Chemistry Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review
Current Drug Targets Role of Vitamin E in Cellular Antioxidant Defense
Current Chemical Biology Chinese Medicinal Herbs as Source of Antioxidant Compounds – Where Tradition Meets the Future
Current Medicinal Chemistry Adipose Tissue Derived Stem Cells Secretome: Soluble Factors and Their Roles in Regenerative Medicine
Current Stem Cell Research & Therapy Nanomedicine and its Potential for the Treatment of Alzheimer’s Disease
Current Nanomedicine Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia
Current Neurovascular Research EDITORIAL: Current Views on Neurodegeneration: Computational to Clinical Research
Current Topics in Medicinal Chemistry Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms
Current Protein & Peptide Science Synthesis and Biological Activities of Some Novel 2-Amino-(5 or 7-Substituted- 2-Oxoindolin-3-Ylidene) Benzoxazole-5-Carbohydrazide Derivatives
Letters in Drug Design & Discovery Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography/Mass Spectrometry
Central Nervous System Agents in Medicinal Chemistry SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications
Pharmaceutical Nanotechnology After Thalidomide – Do We Have the Right Balance Between Public Health and Intellectual Property
Reviews on Recent Clinical Trials Evidence for the Role of Luteinizing Hormone in Alzheimer Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters Minocycline and Cytoprotection: Shedding New Light on a Shadowy Controversy
Current Drug Delivery Brain Drug Delivery Systems for Neurodegenerative Disorders
Current Pharmaceutical Biotechnology Intracompartmental Delivery of CNTF as Therapy for Huntingtons Disease and Retinitis Pigmentosa
Current Gene Therapy